Impact of Substance Use Navigators on Initiation of Treatment for Substance Use Disorders and 30-Day Unplanned Readmission

作者：Arianna Campbell, Allison D. Rosen, Steven Shoptaw, Andrew A. Herring, David C. Jay, Aimee Moulin, Juliet LaMers, Elizabeth A. Samuels, Lindsay Gietzen · 发表于：Journal of General Internal Medicine · 年份：2025 · DOI：10.1007/s11606-025-09902-y · 被引用次数：2 · 研究领域：Substance Abuse Treatment and Outcomes、Opioid Use Disorder Treatment、Forensic Toxicology and Drug Analysis

BACKGROUND: The prevalence of substance use disorders (SUDs) is high among hospitalized patients, yet adoption of evidence-based practices to address SUDs in this population is limited. Substance use navigators (SUNs) are a promising intervention for improving patient outcomes. OBJECTIVE: This study aimed to quantify the impact of SUN consultations on medications for opioid use disorder (MOUD) and medications for alcohol use disorder (MAUD) initiation and 30-day unplanned readmissions in hospitalized patients with SUDs. DESIGN: A retrospective observational cohort study at a rural hospital in Northern California following adoption of the CA Bridge model of using SUNs to provide low-threshold, evidence-based treatment for SUDs. Patient data were extracted from electronic medical records. PATIENTS: Hospitalized patients with a primary or secondary diagnosis of alcohol use disorder or opioid use disorder in 2023. MAIN MEASURES: The two outcomes of interest were MOUD and MAUD initiation and 30-day unplanned readmission. Propensity score matching was used to estimate risk ratios comparing outcomes for patients who did vs. did not receive SUN consultation. KEY RESULTS: Among 781 patients, 26.6% received a SUN consultation and the most common primary diagnosis was sepsis (9%). MOUD and MAUD were initiated among 15.7% of patients who had a SUN consultation and 7% who did not, and the 30-day unplanned readmission rate was 4% for patients who had a SUN consultation and 10.9% for those ...